Search found 5 matches

by reko17
18 Apr 2015, 15:16
Forum: Notes
Topic: Anticoagulants perioperatively
Replies: 0
Views: 12771

Anticoagulants perioperatively

Anticoagulants perioperatively WARFARIN Warfarin is a coumarin derivative It acts by inhibiting vitamin K synthesis and thereby limiting the coagulation factors that are dependent on vitamin K for their production.  These include factors II, VII, IX, X and proteins C and S.  How does loading of Warf...
by reko17
18 Apr 2015, 14:56
Forum: Notes
Topic: BASAL CELL CARCINOMA
Replies: 0
Views: 12728

BASAL CELL CARCINOMA

BASAL CELL CARCINOMA Basal cell carcinoma is a slow growing, non-melanoma skin cancer, that is locally invasive. It originates from the basal cell layers of the epidermis. It is the most common types of skin cancer (>75%) affecting the UK population.  Common risk factors for BCC Exposure to sunlight...
by reko17
17 Apr 2015, 02:52
Forum: Break Time
Topic: Surgery Versus Medicine
Replies: 0
Views: 16042

Surgery Versus Medicine

Surgery Versus Medicine Alexa Mieses, Medical Student, 09:46AM Apr 13, 2015 If medicine were the military, surgeons would be the Navy SEALs. They start their day in the wee hours of the morning. They stand in the OR all day, forgoing water, food and bathroom breaks. They remain at the hospital until...
by reko17
17 Apr 2015, 02:48
Forum: Notes
Topic: Interferon-free Regimen Effective for Genotype-4 Chronic Hepatitis C
Replies: 0
Views: 12940

Interferon-free Regimen Effective for Genotype-4 Chronic Hepatitis C

Interferon-free Regimen Effective for Genotype-4 Chronic Hepatitis C NEW YORK (Reuters Health) - An all-oral, interferon-free regimen consisting of ombitasvir, paritaprevir and ritonavir is effective at treating patients with genotype-4 chronic hepatitis C virus (HCV), according to a new report from...
by reko17
17 Apr 2015, 02:43
Forum: Notes
Topic: First Clinical Evidence' of Remyelination in MS
Replies: 0
Views: 12863

First Clinical Evidence' of Remyelination in MS

First Clinical Evidence' of Remyelination in MS:- Researchers are reporting what they call "the first clinical study to show evidence of proof of biology for remyelination in multiple sclerosis [MS] with a drug therapy." The research team from Biogen report that patients with optic neuriti...

Go to advanced search